PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
405.55%
Net income growth above 1.5x MRVL's 52.30%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.20%
Negative yoy D&A while MRVL is 2.78%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.24%
Well above MRVL's 17.62% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
5.04%
Some inventory rise while MRVL is negative at -199.63%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
29.82%
Lower 'other working capital' growth vs. MRVL's 131.54%. David Dodd would see fewer unexpected short-term demands on cash.
-141.19%
Negative yoy while MRVL is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
101.50%
Operating cash flow growth above 1.5x MRVL's 36.49%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
15.46%
Some CapEx rise while MRVL is negative at -51.22%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-157.44%
Negative yoy purchasing while MRVL stands at 69.14%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
21.56%
Liquidation growth of 21.56% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-205.25%
We reduce yoy invests while MRVL stands at 58.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
139.60%
Stock issuance far above MRVL's 14.07%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.